Vitamine D et maladie d’Alzheimer : d’une curieuse idée à une possibilité de traitement

Accès gratuit

Numéro		Biologie Aujourd'hui Volume 208, Numéro 1, 2014


Page(s)		89 - 95
Section		La vitamine D, une hormone stéroïde méconnue
DOI		https://doi.org/10.1051/jbio/2014005
Publié en ligne		23 juin 2014

Aisen P.S., Pre-dementia Alzheimer’s trials: overview. J Nutr Health Aging, 2010, 14, 294. [CrossRef] [PubMed] [Google Scholar]
Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P., Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron, 1995, 15, 961–973. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Beauchet O., Vitamin D-mentia: randomized clinical trials should be the next step. Neuroepidemiology, 2011, 37, 249–258. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Beauchet O., Possibility of a new anti-alzheimer’s disease pharmaceutical composition combining memantine and vitamin D. Drugs Aging, 2012, 29, 81–91. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Beauchet O., Vitamin D and cognition: recommendations for future trials. J Am Geriatr Soc, 2013, 61, 1049–1050. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Allali G., Allain P., Bridenbaugh S., Schott A.M., Kressig R.W., Beauchet O., Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol, 2009, 16, 1083–1089. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Schott A.M., Berrut G., Chauviré V., Le Gall D., Inzitari M., Beauchet O., Vitamin D and ageing: neurological issues. Neuropsychobiology, 2010a, 62, 139–150. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Schott A.M., Allali G., Bridenbaugh S.A., Kressig R.W., Allain P., Herrmann F.R., Beauchet O., Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 2010b, 74, 27–32. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Le Gall D., Fantino B., Beauchet O., Tucker K.L., Buell J.S., 25-hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010c, 75, 95. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Schott A.M., Rolland Y., Blain H., Herrmann F.R., Beauchet O., Dietary intake of vitamin D and cognition in older women: a large population-based study. Neurology 2010d, 75, 1810–1816. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Souberbielle J.C., Schott A.M., de Decker L., Berrut G., Beauchet O., Vitamin D in the elderly: 5 points to remember. Geriatr Psychol Neuropsychiatr Vieil, 2011a, 9, 259–267. [PubMed] [Google Scholar]
Annweiler C., Fantino B., Le Gall D., Schott A.M., Berrut G., Beauchet O., Severe vitamin D deficiency is associated with advanced-stage dementia in geriatric inpatients. J Am Geriatr Soc, 2011b, 59, 169–171. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Rolland Y., Schott A.M., Blain H., Vellas B., Beauchet O., Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. Dement Geriatr Cogn Disord, 2011c, 32, 273–278. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Fantino B., Parot E., Thiéry S., Gautier J., Beauchet O., Alzheimer’s Disease – Input of vitamin D with memantine Assay: A double-blind randomized placebo-controlled trial (AD-IDEA Trial). Trials, 2011d, 12, 230. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Fantino B., Schott A.M., Krolak-Salmon P., Allali G., Beauchet O., Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. Eur J Neurol, 2012a, 19, 1023–1029. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Rolland Y., Schott A.M., Blain H., Vellas B., Herrmann F.R., Beauchet O., Higher vitamin D dietary intake is associated with lower risk of Alzheimer’s disease: a 7-year follow-up. J Gerontol A Biol Sci Med Sci, 2012b, 67, 1205–1211. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Fantino B., Gautier J., Beaudenon M., Thiéry S., Beauchet O., Cognitive effects of vitamin D supplementation in older outpatients visiting a memory clinic: a pre-post study. J Am Geriatr Soc, 2012c, 60, 793–795. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Herrmann F.R., Fantino B., Brugg B., Beauchet O., Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: a pre-post pilot study. Cogn Behav Neurol, 2012d, 25, 121–127. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Montero-Odasso M., Hachinski V., Seshadri S., Bartha R., Beauchet O., Vitamin D concentration and lateral cerebral ventricle volume in older adults. Mol Nutr Food Res, 2013a, 57, 267–276. [CrossRef] [PubMed] [Google Scholar]
Annweiler C., Montero-Odasso M., Llewellyn D.J., Richard-Devantoy S., Duque G., Beauchet O., Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J Alzheimers Dis, 2013b, 37, 147–171. [PubMed] [Google Scholar]
Annweiler C., Llewellyn D.J., Beauchet O., Low serum vitamin D concentrations in Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis, 2013c, 33, 659–674. [PubMed] [Google Scholar]
Annweiler C., Brugg B., Peyrin J.M., Bartha R., Beauchet O., Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate. Neurobiol Aging, 2014, 35, 331–335. [CrossRef] [PubMed] [Google Scholar]
Balion C., Griffith L.E., Strifler L., Henderson M., Patterson C., Heckman G., Llewellyn D.J., Raina P., Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology, 2012, 79, 1397–1405. [CrossRef] [PubMed] [Google Scholar]
Brewer L.D., Thibault V., Chen K.C., Langub M.C., Landfield P.W., Porter N.M., Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci, 2001, 21, 98–108. [PubMed] [Google Scholar]
Brown J., Bianco J.I., McGrath J.J., Eyles D.W., 1,25-Dihydroxyvitamin D-3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett, 2003, 343, 139–143. [CrossRef] [PubMed] [Google Scholar]
Burns J.M., Johnson D.K., Watts A., Swerdlow R.H., Brooks W.M., Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol, 2010, 67, 428–433. [CrossRef] [PubMed] [Google Scholar]
Camicioli R.M., Kaye J.A., Brummel-Smith K., Recognition of neurologic diseases in geriatric inpatients. Acta Neurol Scand, 1998, 97, 265–270. [PubMed] [Google Scholar]
Cavalli A., Bolognesi M.L., Minarini A., Rosini M., Tumiatti V., Recanatini M., Melchiorre C., Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem, 2008, 51, 347–372. [CrossRef] [PubMed] [Google Scholar]
Dean A.J., Bellgrove M.A., Hall T., Phan W.M., Eyles D.W., Kvaskoff D., McGrath J.J., Effects of vitamin D supplementation on cognitive and emotional functioning in young adults–a randomised controlled trial. PLoS One, 2011, 6, e25966. [CrossRef] [PubMed] [Google Scholar]
Dubois B., Update on Alzheimer’s diseases. Ann Pharm Fr, 2009, 67, 116–126. [CrossRef] [PubMed] [Google Scholar]
Etgen T., Sander D., Bickel H., Sander K., Forstl H., Vitamin D deficiency, cognitive impairment and dementia: A systematic review and meta-analysis. Dement Geriatr Cogn Disord, 2012, 33, 297–305. [CrossRef] [PubMed] [Google Scholar]
Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., Wion D., New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab, 2002, 13, 100–105. [CrossRef] [PubMed] [Google Scholar]
Gezen-Ak D., Dursun E., Ertan T., Hanagasi H., Gürvit H., Emre M., Eker E., Oztürk M., Engin F., Yilmazer S., Association between vitamin D receptor gene polymorphism and Alzheimer’s disease. Tohoku J Exp Med, 2007, 212, 275–282. [CrossRef] [PubMed] [Google Scholar]
Holick M.F., Vitamin D deficiency. N Engl J Med, 2007, 357, 266–281. [CrossRef] [PubMed] [Google Scholar]
Ibi M., Sawada H., Nakanishi M., Kume T., Katsuki H., Kaneko S., Shimohama S., Akaike A., Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology, 2001, 40, 761–771. [CrossRef] [PubMed] [Google Scholar]
Ito S., Ohtsuki S., Nezu Y., Koitabashi Y., Murata S., Terasaki T., 1α, 25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide(1–40) from mouse brain across the blood-brain barrier. Fluids Barriers CNS, 2011, 8, 20. [CrossRef] [PubMed] [Google Scholar]
Johansson P., Almqvist E.G., Johansson J.O., Mattsson N., Andreasson U., Hansson O., Wallin A., Blennow K., Zetterberg H., Svensson J., Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer’s disease. PLoS One, 2013, 8, e81989. [CrossRef] [PubMed] [Google Scholar]
Kalueff A.V., Tuohimaa P., Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care, 2007, 10, 12–19. [CrossRef] [PubMed] [Google Scholar]
Masoumi A., Goldenson B., Ghirmai S., Avagyan H., Zaghi J., Abel K., Zheng X., Espinosa-Jeffrey A., Mahanian M., Liu P.T., Hewison M., Mizwickie M., Cashman J., Fiala M., 1alpha,25-dihydroxyvitamin D₃ interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer’s disease patients. J Alzheimers Dis, 2009, 17, 703–717. [PubMed] [Google Scholar]
Moon M., Song H., Hong H.J., Nam D.W., Cha M.Y., Oh M.S., Yu J., Ryu H., Mook-Jung I., Vitamin D-binding protein interacts with Abeta and suppresses Abeta-mediated pathology. Cell Death Differ, 2013, 20, 630–638. [CrossRef] [PubMed] [Google Scholar]
Oudshoorn C., Mattace-Raso F.U., van der Velde N., Colin E.M., van der Cammen T.J., Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer’s disease. Dement Geriatr Cogn Disord, 2008, 25, 539–543. [CrossRef] [PubMed] [Google Scholar]
Perl D.P., Neuropathology of Alzheimer’s disease. Mt Sinai J Med, 2010, 77, 32–42. [CrossRef] [PubMed] [Google Scholar]
Przybelski R., Agrawal S., Krueger D., Engelke J.A., Walbrun F., Binkley N., Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int, 2008, 19, 1621–1628. [CrossRef] [PubMed] [Google Scholar]
Riaz S., Malcangio M., Miller M., Tomlinson D.R., A vitamin D₃ derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin diabetic rats. Diabetologia, 1999, 42, 1308–1313. [CrossRef] [PubMed] [Google Scholar]
Stein M.S., Scherer S.C., Ladd K.S., Harrison L.C., A randomized controlled trial of high-dose vitamin D₂ followed by intranasal insulin in Alzheimer’s disease. J Alzheimers Dis, 2011, 26, 477–484. [CrossRef] [PubMed] [Google Scholar]
Sokolow S., Luu S.H., Vinters H.V., Miller C.A., Gylys K.H. Glutamatergic (VGLUT1) synapses are not lost in Alzheimer’s disease cerebral cortex, but preferentially accumulate amyloid-beta and p-tau pathology. Alzheimers Dement, 2010, 6, S243. [CrossRef] [Google Scholar]
Sonnenberg J., Luine V.N., Krey L.C., Christakos S., 1,25-dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. Endocrinology, 1986, 118, 1433–1439. [CrossRef] [PubMed] [Google Scholar]
Sutherland M.K., Somerville M.J., Yoong L.K., Bergeron C., Haussler M.R., McLachlan D.R., Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res, 1992, 13, 239–250. [CrossRef] [PubMed] [Google Scholar]
Walton H.S., Dodd P.R., Glutamate-glutamine cycling in Alzheimer’s disease. Neurochem Int, 2007, 50, 1052–1066. [CrossRef] [PubMed] [Google Scholar]
Wang Y., Chiang Y.H., Su T.P., Hayashi T., Morales M., Hoffer B.J., Lin S.Z., Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology, 39, 2000, 873–880. [CrossRef] [PubMed] [Google Scholar]
Yu J., Gattoni-Celli M., Zhu H., Bhat N.R., Sambamurti K., Gattoni-Celli S., Kindy M.S., Vitamin D₃-Enriched Diet Correlates with a Decrease of Amyloid Plaques in the Brain of AbetaPP Transgenic Mice. J Alzheimers Dis, 2011, 25, 295–307. [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.